Related Experiment Video
Updated: Feb 28, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
12.1K
Type 2 Diabetes Is Associated with Increased Coagulation Activity in Patients with Atrial Fibrillation: A
Paul Gabriel Ciubotaru1, Amit Kohli2, Nilima Rajpal Kundnani3,4
1Department V, Internal Medicine I-Discipline of Medical Semiology I, Center of Advanced Research in Cardiology and Hemostasology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Biomedicines
|February 27, 2026
Summary
Type 2 diabetes mellitus (T2DM) in atrial fibrillation (AF) patients is linked to higher D-dimer levels, indicating increased coagulation. This suggests a diabetes-associated hypercoagulable AF phenotype, independent of stroke risk factors.
Area of Science:
- Cardiology
- Endocrinology
- Hematology
Background:
- Atrial Fibrillation (AF) increases stroke risk due to a prothrombotic state.
- Type 2 Diabetes Mellitus (T2DM) is a common comorbidity in AF patients, independently raising thromboembolic risk.
- The impact of T2DM on D-dimer levels in AF patients requires further real-world characterization.
Purpose of the Study:
- To investigate the independent association between T2DM and plasma D-dimer levels in non-valvular AF patients.
- To analyze D-dimer levels across different CHA2DS2-VASc risk categories in AF patients with and without T2DM.
- To assess the role of T2DM in exacerbating the prothrombotic state in AF.
Main Methods:
- Retrospective, observational study of 300 non-valvular AF patients.
- Stratification into two groups: 150 with T2DM and 150 without diabetes.
- Multivariable regression models adjusted for clinical factors, renal function, and anticoagulation status.
Main Results:
- Patients with T2DM had significantly higher D-dimer levels (median 0.94 vs. 0.63 µg/mL FEU, p < 0.001).
- T2DM was independently associated with elevated D-dimer levels and increased odds of exceeding thresholds (0.5 and 1.0 µg/mL FEU).
- Higher D-dimer concentrations in T2DM patients were consistent across all CHA2DS2-VASc risk categories.
Conclusions:
- T2DM is independently associated with increased coagulation activity in AF patients, evidenced by higher D-dimer levels.
- Findings support a distinct 'diabetes-associated hypercoagulable AF phenotype'.
- Coagulation biomarkers like D-dimer may refine risk stratification in AF patients with T2DM.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:30Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
399
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
399